Restructuring and Other Impairment Charges - Additional Information (Detail) (USD $)	3 Months Ended	9 Months Ended	3 Months Ended	9 Months Ended	12 Months Ended	3 Months Ended		9 Months Ended		12 Months Ended	3 Months Ended	9 Months Ended		9 Months Ended		3 Months Ended	9 Months Ended	12 Months Ended		12 Months Ended	3 Months Ended	9 Months Ended	3 Months Ended		9 Months Ended
	Sep. 29, 2013	Sep. 29, 2013	Sep. 29, 2013 2012 Restructuring Charges	Sep. 29, 2013 2012 Restructuring Charges	Dec. 31, 2012 2012 Restructuring Charges Facility	Sep. 29, 2013 2007 Arrow Integration Program	Sep. 30, 2012 2007 Arrow Integration Program	Sep. 29, 2013 2007 Arrow Integration Program	Sep. 30, 2012 2007 Arrow Integration Program	Dec. 31, 2012 2007 Arrow Integration Program	Sep. 29, 2013 LMA Restructuring Program	Sep. 29, 2013 LMA Restructuring Program	Dec. 31, 2012 LMA Restructuring Program	Sep. 29, 2013 LMA Restructuring Program Contract Termination Costs	Dec. 31, 2012 LMA Restructuring Program Contract Termination Costs	Sep. 30, 2012 2011 Restructuring Program	Sep. 30, 2012 2011 Restructuring Program	Dec. 31, 2011 2011 Restructuring Program Facility	Sep. 29, 2013 2011 Restructuring Program	Dec. 31, 2011 2011 Restructuring Program Contract Termination Costs	Sep. 29, 2013 2013 Restructuring Program	Sep. 29, 2013 2013 Restructuring Program	Mar. 31, 2013 Axiom Technology Partners LLC	Sep. 29, 2013 North America and Europe 2013 Restructuring Program	Sep. 29, 2013 North America and Europe 2013 Restructuring Program
Restructuring Cost and Reserve [Line Items]
Expected restructuring charges														$ 7,000,000						$ 2,700,000
Restructuring charges			1,100,000	4,200,000		38,000	41,000	173,000	(1,834,000)		1,768,000	8,364,000				(60,000)	(60,000)				826,000	8,656,000		800,000	8,700,000
Restructuring reserve			2,500,000	2,500,000		400,000		400,000			2,311,000	2,311,000	2,033,000	800,000	277,000				1,300,000					3,000,000	3,000,000
Number of facilities under restructuring program					3													3
Contract termination costs									2,023,000	2,000,000	(1,097,000)	(4,378,000)
In-process research and development impairment		4,494,000																					4,500,000
Impairment charges related to assets held for sale	$ 3,354,000	$ 3,354,000